Related Experiment Video
Updated: Jul 18, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Use of modified U1 snRNAs to inhibit HIV-1 replication
Nucleic Acids Research
|December 13, 2006
Summary
Modified U1 small nuclear RNA (snRNA) targeting conserved regions in HIV-1 RNA significantly suppressed viral protein expression and replication. This RNA processing control strategy shows potential as a novel HIV therapeutic.
Area of Science:
- Molecular Biology
- Virology
- RNA Processing
Background:
- RNA processing, specifically 3' polyadenylation, is crucial for regulating Human Immunodeficiency Virus type 1 (HIV-1) replication.
- Targeted binding of modified U1 small nuclear RNA (snRNA) can disrupt mRNA polyadenylation.
Purpose of the Study:
- To investigate if U1 snRNAs binding to conserved regions in HIV-1's terminal exon can inhibit viral structural protein expression.
- To assess the potential of U1 snRNA-based therapeutics for controlling HIV-1.
Main Methods:
- Designed and utilized U1 snRNAs complementary to conserved 10-nucleotide regions within the terminal exon of HIV-1.
- Assessed the impact of U1 snRNA binding on HIV-1 protein expression, viral replication, and viral RNA levels.
- Mutated U1 snRNA to analyze the dependence of antiviral activity on U1 snRNP particle assembly (U1 70K, Sm proteins, U1A binding sites).
Main Results:
- U1 snRNAs targeting 5 out of 15 conserved regions significantly suppressed HIV-1 protein expression and replication.
- Suppression correlated with a reduction in viral RNA levels.
- Antiviral efficacy was dependent on U1 snRNP assembly; mutations affecting U1 70K or Sm protein binding reduced efficacy.
- Constructs lacking U1A binding sites maintained significant antiviral activity, suggesting potential for reduced toxicity.
Conclusions:
- Targeting conserved sequences in HIV-1 with modified U1 snRNAs is an effective strategy to inhibit viral gene expression and replication.
- The assembly of U1 snRNP particles is critical for the antiviral activity of these constructs.
- U1 snRNA-based therapeutics hold promise for HIV treatment, with potential for tailored applications based on U1A binding site modifications.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...